vs
Side-by-side financial comparison of Dexcom (DXCM) and OCEANEERING INTERNATIONAL INC (OII). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $692.4M, roughly 1.8× OCEANEERING INTERNATIONAL INC). Dexcom runs the higher net margin — 21.2% vs 5.2%, a 16.0% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 3.6%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs 1.8%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
Oceaneering International, Inc. is a subsea engineering and applied technology company based in Houston, Texas, U.S. that provides engineered services and hardware to customers who operate in marine, space, and other environments.
DXCM vs OII — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $692.4M |
| Net Profit | $267.3M | $36.1M |
| Gross Margin | 62.9% | — |
| Operating Margin | 25.6% | — |
| Net Margin | 21.2% | 5.2% |
| Revenue YoY | 21.6% | 3.6% |
| Net Profit YoY | 153.6% | -28.3% |
| EPS (diluted) | $0.67 | $0.36 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | $692.4M | ||
| Q4 25 | $1.3B | $668.6M | ||
| Q3 25 | $1.2B | $742.9M | ||
| Q2 25 | $1.2B | $698.2M | ||
| Q1 25 | $1.0B | $674.5M | ||
| Q4 24 | $1.1B | $713.5M | ||
| Q3 24 | $994.2M | $679.8M | ||
| Q2 24 | $1.0B | $668.8M |
| Q1 26 | $267.3M | $36.1M | ||
| Q4 25 | $267.3M | $177.7M | ||
| Q3 25 | $283.8M | $71.3M | ||
| Q2 25 | $179.8M | $54.4M | ||
| Q1 25 | $105.4M | $50.4M | ||
| Q4 24 | $151.7M | $56.1M | ||
| Q3 24 | $134.6M | $41.2M | ||
| Q2 24 | $143.5M | $35.0M |
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | 19.8% | ||
| Q3 25 | 60.5% | 20.6% | ||
| Q2 25 | 59.5% | 21.3% | ||
| Q1 25 | 56.9% | 20.0% | ||
| Q4 24 | 58.9% | 19.9% | ||
| Q3 24 | 59.7% | 19.3% | ||
| Q2 24 | 62.4% | 18.0% |
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | 9.8% | ||
| Q3 25 | 20.1% | 11.6% | ||
| Q2 25 | 18.4% | 11.3% | ||
| Q1 25 | 12.9% | 10.9% | ||
| Q4 24 | 17.0% | 10.9% | ||
| Q3 24 | 15.3% | 10.5% | ||
| Q2 24 | 15.7% | 9.0% |
| Q1 26 | 21.2% | 5.2% | ||
| Q4 25 | 21.2% | 26.6% | ||
| Q3 25 | 23.5% | 9.6% | ||
| Q2 25 | 15.5% | 7.8% | ||
| Q1 25 | 10.2% | 7.5% | ||
| Q4 24 | 13.6% | 7.9% | ||
| Q3 24 | 13.5% | 6.1% | ||
| Q2 24 | 14.3% | 5.2% |
| Q1 26 | $0.67 | $0.36 | ||
| Q4 25 | $0.67 | $1.75 | ||
| Q3 25 | $0.70 | $0.71 | ||
| Q2 25 | $0.45 | $0.54 | ||
| Q1 25 | $0.27 | $0.49 | ||
| Q4 24 | $0.37 | $0.55 | ||
| Q3 24 | $0.34 | $0.40 | ||
| Q2 24 | $0.35 | $0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | — |
| Total DebtLower is stronger | — | $488.8M |
| Stockholders' EquityBook value | $2.7B | $1.1B |
| Total Assets | $6.3B | $2.6B |
| Debt / EquityLower = less leverage | — | 0.44× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $695.9M | ||
| Q3 25 | $1.8B | $7.0M | ||
| Q2 25 | $1.2B | $7.0M | ||
| Q1 25 | $904.9M | $7.0M | ||
| Q4 24 | $606.1M | $504.5M | ||
| Q3 24 | $621.2M | — | ||
| Q2 24 | $939.2M | — |
| Q1 26 | — | $488.8M | ||
| Q4 25 | — | $487.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $482.0M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $2.7B | $1.1B | ||
| Q4 25 | $2.7B | $1.1B | ||
| Q3 25 | $2.7B | $907.7M | ||
| Q2 25 | $2.6B | $842.1M | ||
| Q1 25 | $2.3B | $773.1M | ||
| Q4 24 | $2.1B | $714.3M | ||
| Q3 24 | $2.0B | $698.0M | ||
| Q2 24 | $2.4B | $651.0M |
| Q1 26 | $6.3B | $2.6B | ||
| Q4 25 | $6.3B | $2.7B | ||
| Q3 25 | $7.5B | $2.5B | ||
| Q2 25 | $7.3B | $2.3B | ||
| Q1 25 | $6.8B | $2.3B | ||
| Q4 24 | $6.5B | $2.3B | ||
| Q3 24 | $6.4B | $2.4B | ||
| Q2 24 | $6.8B | $2.3B |
| Q1 26 | — | 0.44× | ||
| Q4 25 | — | 0.46× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.67× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | — |
| Free Cash FlowOCF − Capex | — | $-76.5M |
| FCF MarginFCF / Revenue | — | -11.1% |
| Capex IntensityCapex / Revenue | — | 2.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $238.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $221.1M | ||
| Q3 25 | $659.9M | $101.3M | ||
| Q2 25 | $303.0M | $77.2M | ||
| Q1 25 | $183.8M | $-80.7M | ||
| Q4 24 | $301.4M | $128.4M | ||
| Q3 24 | $199.5M | $91.9M | ||
| Q2 24 | $279.4M | $52.6M |
| Q1 26 | — | $-76.5M | ||
| Q4 25 | $192.1M | $190.7M | ||
| Q3 25 | $579.4M | $77.0M | ||
| Q2 25 | $208.9M | $46.9M | ||
| Q1 25 | $96.8M | $-106.8M | ||
| Q4 24 | $176.8M | $94.5M | ||
| Q3 24 | $88.3M | $67.0M | ||
| Q2 24 | $213.3M | $29.8M |
| Q1 26 | — | -11.1% | ||
| Q4 25 | 15.3% | 28.5% | ||
| Q3 25 | 47.9% | 10.4% | ||
| Q2 25 | 18.1% | 6.7% | ||
| Q1 25 | 9.3% | -15.8% | ||
| Q4 24 | 15.9% | 13.2% | ||
| Q3 24 | 8.9% | 9.9% | ||
| Q2 24 | 21.2% | 4.5% |
| Q1 26 | — | 2.5% | ||
| Q4 25 | 8.1% | 4.6% | ||
| Q3 25 | 6.7% | 3.3% | ||
| Q2 25 | 8.1% | 4.3% | ||
| Q1 25 | 8.4% | 3.9% | ||
| Q4 24 | 11.2% | 4.7% | ||
| Q3 24 | 11.2% | 3.7% | ||
| Q2 24 | 6.6% | 3.4% |
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | 1.24× | ||
| Q3 25 | 2.33× | 1.42× | ||
| Q2 25 | 1.69× | 1.42× | ||
| Q1 25 | 1.74× | -1.60× | ||
| Q4 24 | 1.99× | 2.29× | ||
| Q3 24 | 1.48× | 2.23× | ||
| Q2 24 | 1.95× | 1.50× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
